Earnings Call · Q4 FY2025·2026-02-24

Q4 25EPS -21.26%·Rev n/aQ3 25EPS +14.29%·Rev n/aQ2 25EPS +52.63%·Rev n/aQ1 25EPS +21.43%·Rev n/a⚠ consensus missing

CORCEPT THERAPEUTICS INC CORT

Atabak Mokari — Chief Financial Officer

Gary Robb — Chief Executive Officer

Sean Maduck — Chief Commercial Officer

Joseph K. Belanoff — Chairman and Chief Executive Officer

+3.2%1d on move date+2.5% vs SPY3d+1.2%5d+1.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CORT calls or request research access.

More CORT calls Browse calls Request research access